Late Worsening of COVID-19 Pneumonia: Successful Treatment with Ruxolitinib and Steroid
We describe the case of a patient hospitalized for the second time in a month due to delayed worsening of lung lesions in COVID-19 infection without bacterial superinfection. He was treated with hydroxychloroquine, IV dexamethasone and ruxolitinib with rapid improvement of respiratory failure; 1 mon...
Main Authors: | Mauro Betelli, Fabio De Stefano, Alberto Tedeschi |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2020-10-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/1938 |
Similar Items
-
Ruxolitinib treatment permits lower cumulative glucocorticoid dosing in children with secondary hemophagocytic lymphohistiocytosis
by: Ying Chi, et al.
Published: (2021-04-01) -
Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis
by: Novella Pugliese, et al.
Published: (2019-06-01) -
Successful treatment of alopecia totalis with ruxolitinib in a preadolescent patient
by: Danielle M. Peterson, MD, et al.
Published: (2020-04-01) -
Pulmonary cryptococcosis in a ruxolitinib-treated patient with primary myelofibrosis
by: Anna Hirano, et al.
Published: (2017-01-01) -
Delayed granulomatous eruption of the nose associated with ruxolitinib
by: Margaret Brown, MD, et al.
Published: (2020-07-01)